96% Of S&P 500 Stocks Show Upside Potential Vs. Street Estimates: Which Offers The Best Opportunity?
Once Valued At Billions, 23andMe's CEO Considers Privatization To Secure Company's Future
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious'
Neurodegenerative Disorder-Focused Sage Therapeutics Stock Falls On Disappointing Parkinson's Data
Biotech Recent News
Why Is Gene Therapy Developer Benitec Biopharma Stock Trading Higher On Thursday?
Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025
Krystal Biotech is on the Move, Here's Why the Trend Could be Sustainable
Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future
Is Your Botox Real Or Fake? Counterfeit Boxes Circulate For Widely Used Antiwrinkle Treatment, CDC And FDA Investigate Harmful Reactions
Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick
Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share
Novartis Multiple Sclerosis Drug Kesimpta Shows Substantial Benefit Of Up To 6 Years
Sanofi's Multiple Sclerosis Antibody Shows Reduction Of Disease Activity
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Eli Lilly's Famed Weight Loss Drug Zepbound Works As Sleep Apnea Treatment, Successful Late-Stage Studies Show
Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More
GSK Says Its Blockbuster Shingles Vaccine Shows High Efficacy Even After 10 Years